Publication | Open Access

Allelic imbalance at chromosome 17p13.3 (YNZ22) in breast cancer is independent of p53 mutation or p53 overexpression and is associated with poor prognosis at medium-term follow-up

Tumor BiologyBreast OncologyAllelic ImbalanceGeneticsMedicineP53 MutationPathologyCancer GenomicsBreast CancerCancer BiologyCancer GeneticsOncologyCancer Research